Greenwich LifeSciences (GLSI) Profit After Tax (2019 - 2025)
Greenwich LifeSciences (GLSI) posted Profit After Tax of -$9.2 million for Q4 2025, down 146.64% on a QoQ basis from -$3.7 million in Q3 2025, and up 5.3% year-over-year from -$8.7 million in Q4 2024.
Greenwich LifeSciences (GLSI) Profit After Tax (2019 - 2025) Analysis & Trends
Greenwich LifeSciences' Profit After Tax history runs 7 years deep, the most recent figure standing at -$9.2 million for Q4 2025.
- Quarterly Profit After Tax rose 5.3% year-over-year to -$9.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$19.4 million (down 11.16% YoY) and the FY2025 annual result came in at -$19.4 million, down 11.16% from the prior year.
- Profit After Tax was -$9.2 million for Q4 2025 at Greenwich LifeSciences, down from -$3.7 million in the prior quarter.
- Across five years, Profit After Tax topped out at -$597008.0 in Q1 2021 and bottomed at -$9.7 million in Q4 2024.
- A 5-year average of -$2.9 million and a median of -$2.4 million in 2023 frame the typical range for Profit After Tax.
- Annual changes were most pronounced in 2021 — Profit After Tax slumped 256.29% — and 2025, when it rose 5.3%.
- Greenwich LifeSciences' Profit After Tax stood at -$2.4 million in 2021, then fell by 18.21% to -$2.8 million in 2022, then rose by 1.57% to -$2.7 million in 2023, then slumped by 251.89% to -$9.7 million in 2024, then climbed by 5.3% to -$9.2 million in 2025.
- Business Quant data shows GLSI's Profit After Tax at -$9.2 million in Q4 2025, -$3.7 million in Q3 2025, and -$3.7 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -36.84 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 227.36 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.03 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -65.60 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 362.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -453.82 Mn |
| 10 | Greenwich LifeSciences | 178.53 Mn | 178.53 Mn | - | -9.15 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -9.15 Mn |
| Sep 30, 2025 | -3.71 Mn |
| Jun 30, 2025 | -3.75 Mn |
| Mar 31, 2025 | -2.74 Mn |
| Dec 31, 2024 | -9.67 Mn |
| Sep 30, 2024 | -2.67 Mn |
| Jun 30, 2024 | -2.61 Mn |
| Mar 31, 2024 | -2.47 Mn |
| Dec 31, 2023 | -2.75 Mn |
| Sep 30, 2023 | -2.39 Mn |
| Jun 30, 2023 | -1.63 Mn |
| Mar 31, 2023 | -2.12 Mn |
| Dec 31, 2022 | -2.79 Mn |
| Sep 30, 2022 | -2.32 Mn |
| Jun 30, 2022 | -746,073.00 |
| Mar 31, 2022 | -1.97 Mn |
| Dec 31, 2021 | -2.36 Mn |
| Sep 30, 2021 | -863,118.00 |
| Jun 30, 2021 | -749,745.00 |
| Mar 31, 2021 | -597,008.00 |